For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Fidaxomicin | Standard 10-day fidaxomicin treatment for Clostridium difficile Fidaxomicin: 200 mg PO twice daily for 10 days | 8 | None | 34 | 102 | 7 | 102 | View |
| Vancomycin T/P | Standard 10-day vancomycin treatment followed by taper and pulse vancomycin treatment for Clostridium difficile Vancomycin with Taper/Pulse: 125 mg PO four times daily for 10 days, followed by 125 mg once daily x 7 days, then once every other day x 7 days, then once every 3rd day x 7 days | 2 | None | 30 | 100 | 15 | 100 | View |
| Vancomycin | Standard 10-day vancomycin treatment for Clostridium difficile Vancomycin: 125 mg PO for times daily for 10 days | 3 | None | 27 | 100 | 12 | 100 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Cardiac failure | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Mycardinal infection | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Cardiogenic shock | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Pancreatitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Upper Gastrointestinal hemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| chest pain | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| complication associated with device | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| death | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Pyrexia | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Asthenia | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Physical deconditioning | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Cellulitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Clostridium difficile infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Pneumonia | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Bacteraemia | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Cardiac valve vegetation | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Clostridium difficile colitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Septic shock | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Appendicitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| COVID-19 pneumonia | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Clostridial sepsis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Fall | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Alcohol poisoning | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Fracture | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Renal lymphocele | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Dehydration | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hypoglycaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hyperkaliemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hypervolaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Arthralgia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Haemorrhage intracranial | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Encephalopathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Cerebrovascular accident | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| metabolic encephalopathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Alcohol abuse | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Alcohol withdrawal | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Substance abuse | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Suicidal ideation | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Suicide attempt | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Acute kidney injury | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| End stage renal disease | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Haematuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Pleural effusion | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Respiratory failure | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Chronic Obstructive Pulmonary disease | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Dyspnoea exertional | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Homeless | SYSTEMATIC_ASSESSMENT | Social circumstances | None | View |
| Alcohol detoxification | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |
| Amputation | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |
| Intraocular Lens Implant | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |
| Knee Arthroplasty | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |
| Arteriovenous fistula operation | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |
| Hypotension | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Orthostatic hypotension | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Anaemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Cholecystitis | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| Anaphylactic reaction | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| Metastases to bone | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Myelodysplastic syndrome | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Pancreatic carcinoma | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Colon cancer stage IV | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Diffuse large B-cell lymphoma | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Skin ulcer | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Decubitus ulcer | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Catheterisation cardiac | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Device occlusion | SYSTEMATIC_ASSESSMENT | Product Issues | None | View |
| Arrhythmia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Sepsis syndrome | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Urinary tract Infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Urosepsis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Abdominal distension | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Diarrhoea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Dysepsia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Abdominal pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Abdominal pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Neutrophil count decrease | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Drug eruption | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Pruritis | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Hyperhidrosis | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Erythema | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Hepatic steatosis | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| Tremor | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Emotional distress | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Abdominal distension | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Diarrhoea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Frequent bowel movements | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Clostridioide difficile infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Fungal infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Conjunctivitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Hepatic enzyme increased | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| White blood cell count | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| White blood cell count | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Alanine aminotransferase | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Aspartate aminotransferase | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Tachycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Malaise | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Hypotension | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |